- Stuart H. Orkin, MD, chairman of the department of pediatric oncology at Dana-Farber/Children’s Hospital Cancer Center, will receive the Jessie Stevenson Kovalenko Medal at the National Academy of Sciences’ 150th Annual meeting in April.
Tags: BasicResearch, ChildhoodCancer, Honors
- A new study that proposes a three-in-one test for gynecologic cancers underscores the promise of molecular screening for early detection of endometrial and ovarian cancers, but also suggests that such tests are not yet ready for clinical use. Andrea Myers, MD, PhD, a co-author of the commentary on the study, says the test is an important step in that direction.
Tags: CervicalCancer, OvarianCancer, Prevention, GynecologicCancers
- Dana-Farber launches a free, easy-to-use Apple iPhone® app that provides recipes and nutrition information that can be searched by cancer patients, cancer survivors, their families, and anyone who wants to have a healthy diet.
Tags: Nutrition, PatientSupport, Prevention, Survivorship
- A report from the nation's leading cancer organizations shows rates of death in the United States from all cancers for men and women continued to decline between 2000 and 2009. The findings come from the latest Annual Report to the Nation on the Status of Cancer
Tags: CervicalCancer, Prevention, Survivorship, HeadNeckCancers, GynecologicCancers
- Researchers at Dana-Farber/Brigham and Women's Cancer Center report a small percentage of men in a prostate cancer study complained that their penis seemed shorter following treatment, causing them to regret the type of treatment they chose.
Tags: ProstateCancer, PopulationScience
- A national drug shortage has been linked to a higher rate of relapse among Hodgkin lymphoma patients enrolled in a national pediatric clinical trial, report researchers involved in the study.
Tags: chemotherapy, ChildhoodCancer, Lymphoma
- Coping with cancer during the holidays can turn the season from joyful to stressful and full of anxiety. Here's some advice to help patients and their friends and family cope and celebrate this season.
Tags: PatientSupport, Survivorship, CopingWithCancer
- Dana-Farber scientists have discovered a molecular switch that enables advanced prostate cancers to spread without stimulation by male hormones, a finding that could serve as a treatment target for castration-resistant prostate cancers.
Tags: BasicResearch, ProstateCancer
- Dana-Farber Cancer Institute researchers report that when people with a family history of colorectal cancer develop the disease, their tumors often carry a molecular sign that the cancer could be life-threatening.
- Researchers at Dana-Farber/Children's Hospital Cancer Center have taken the first preliminary steps toward developing a form of gene therapy for sickle cell disease.
Showing 31-40 of 401 items